Trials / Not Yet Recruiting
Not Yet RecruitingNCT06644794
Progesterone-modified Natural Cycle for FET
Comparison of Progesterone-modified Natural Cycle and Hormone Replacement Therapy Cycle for Endometrial Preparation in Single Frozen Blastocyst Transfer
- Status
- Not Yet Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 336 (estimated)
- Sponsor
- Shandong University of Traditional Chinese Medicine · Academic / Other
- Sex
- Female
- Age
- 21 Years – 44 Years
- Healthy volunteers
- Not accepted
Summary
Hormone replacement therapy (HRT) cycles, despite the ease of synchronizing embryo thawing and embryo transfer timing, increase the risk of pregnancies and obstetric complications compared to natural cycles (NC). By ensuring the presence of the corpus luteum while reducing the number of monitoring sessions, the progesterone modified natural cycle (P4mNC) offers more convenience for the patient than the normal NC. This study is designed to compare the effects of P4mNC and HRT cycles on FET outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Progesterone-modified natural cycle preparation for frozen embryo transfer | A novel endometrial preparation protocol that optimizes the natural cycle, whereby as long as the thickness of the endometrium is suitable for embryo transfer, vaginal progesterone can be used to transform the endometrium before ovulation and subsequently FET. |
| DRUG | Hormone replacement therapy cycle preparation for frozen embryo transfer | A traditional endometrial preparation protocol is used for FET, which involves using fixed or flexible exogenous estradiol for artificial cycles. This protocol typically involves starting exogenous estradiol on day 3 or 4 of the cycle, continuing for 7-10 days, and then discontinuing. Upon determining that the endometrial thickness meets the standard, progesterone conversion of the endometrium can be performed. |
Timeline
- Start date
- 2024-12-05
- Primary completion
- 2026-09-10
- Completion
- 2027-12-01
- First posted
- 2024-10-16
- Last updated
- 2024-10-16
Source: ClinicalTrials.gov record NCT06644794. Inclusion in this directory is not an endorsement.